| dc.contributor.author |
Esin, E. |
|
| dc.contributor.author |
Oksuzoglu, O. B. Cakmak |
|
| dc.contributor.author |
Bilici, A. |
|
| dc.contributor.author |
Cicin, I. |
|
| dc.contributor.author |
Yumuk, PF |
|
| dc.date.accessioned |
2019-07-18T13:03:17Z |
|
| dc.date.available |
2019-07-18T13:03:17Z |
|
| dc.date.issued |
2018 |
|
| dc.identifier.citation |
Esin, E. Oksuzoglu, OBC. Bilici, A . Cicin, I. Yumuk, PF. (2018). Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: real lifepractice results. Cilt:29. 104-105 ss. |
tr_TR |
| dc.identifier.uri |
http://hdl.handle.net/11616/12755 |
|
| dc.language.iso |
eng |
tr_TR |
| dc.publisher |
Oxford unıv press, great clarendon st, oxford ox2 6dp, england |
tr_TR |
| dc.rights |
info:eu-repo/semantics/restrictedAccess |
tr_TR |
| dc.title |
Pertuzumab, trastuzumab and taxane combination for visceral organ metastatic patients: real lifepractice results |
tr_TR |
| dc.type |
article |
tr_TR |
| dc.relation.journal |
Annals of oncology |
tr_TR |
| dc.contributor.department |
İnönü Üniversitesi |
tr_TR |
| dc.identifier.volume |
29 |
tr_TR |
| dc.identifier.issue |
0 |
tr_TR |
| dc.identifier.startpage |
104 |
tr_TR |
| dc.identifier.endpage |
105 |
tr_TR |